Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 243

Results For "patients"

4121 News Found

Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad
News | April 12, 2023

Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad

The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament


CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
News | April 12, 2023

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells


Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug
Drug Approval | April 11, 2023

Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug

Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.


Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
News | April 10, 2023

Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh

He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir


Thermo Fisher Scientific expands its capabilities in France
News | April 10, 2023

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations


Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
News | April 08, 2023

Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada

The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.


Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.


mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA
Drug Approval | April 07, 2023

mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma


Approx 800 million Indians do not have health coverage, says Expert
Healthcare | April 06, 2023

Approx 800 million Indians do not have health coverage, says Expert

Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand